Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



<i>PUF60</i>-related developmental disorder: A case series and phenotypic analysis of 10 additional patients with monoallelic <i>PUF60</i> variants
Indexado
WoS WOS:001004585600001
Scopus SCOPUS_ID:85161697117
DOI 10.1002/AJMG.A.63313
Año 2023
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



PUF60-related developmental disorder (also referred to as Verheij syndrome), resulting from haploinsufficiency of PUF60, is associated with multiple congenital anomalies affecting a wide range of body systems. These anomalies include ophthalmic coloboma, and congenital anomalies of the heart, kidney, and musculoskeletal system. Behavioral and intellectual difficulties are also observed. While less common than other features associated with PUF60-related developmental disorder, for instance hearing impairment and short stature, identification of specific anomalies such as ophthalmic coloboma can aid with diagnostic identification given the limited spectrum of genes linked with this feature. We describe 10 patients with PUF60 gene variants, bringing the total number reported in the literature, to varying levels of details, to 56 patients. Patients were recruited both via locally based exome sequencing from international sites and from the DDD study in the United Kingdom. Eight of the variants reported were novel PUF60 variants. The addition of a further patient with a reported c449-457del variant to the existing literature highlights this as a recurrent variant. One variant was inherited from an affected parent. This is the first example in the literature of an inherited variant resulting in PUF60-related developmental disorder. Two patients (20%) were reported to have a renal anomaly consistent with 22% of cases in previously reported literature. Two patients received specialist endocrine treatment. More commonly observed were clinical features such as: cardiac anomalies (40%), ocular abnormalities (70%), intellectual disability (60%), and skeletal abnormalities (80%). Facial features did not demonstrate a recognizable gestalt. Of note, but remaining of unclear causality, we describe a single pediatric patient with pineoblastoma. We recommend that stature and pubertal progress should be monitored in PUF60-related developmental disorder with a low threshold for endocrine investigations as hormone therapy may be indicated. Our study reports an inherited case with PUF60-related developmental disorder which has important genetic counseling implications for families.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Genetics & Heredity
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Grimes, H. - Univ Hosp Bristol & Weston NHS Trust - Reino Unido
University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido
2 Ansari, M. - Western Gen Hosp - Reino Unido
Western General Hospital - Reino Unido
3 Ashraf, T. - Great Ormond St Hosp Sick Children - Reino Unido
Great Ormond Street Hospital for Children NHS Foundation Trust - Reino Unido
4 Cueto-Gonzalez, Anna M. Mujer Vall Hebron Barcelona Hosp Campus - España
Autonomous Univ Barcelona - España
Universitat Autònoma de Barcelona - España
5 Calder, A. - Great Ormond St Hosp Sick Children - Reino Unido
Great Ormond Street Hospital for Children NHS Foundation Trust - Reino Unido
6 Day, M. - Royal Devon & Exeter NHS Trust - Reino Unido
Royal Devon and Exeter NHS Foundation Trust - Reino Unido
7 Fernandez Alvarez, P. - Vall Hebron Barcelona Hosp Campus - España
8 Foster, A. - West Midlands Reg Genet Ctr - Reino Unido
West Midlands Regional Genetics Laboratory - Reino Unido
9 Lahiri, N. - St Georges Univ Hosp NHS Fdn Trust - Reino Unido
St Georges Univ London - Reino Unido
St George's University Hospitals NHS Foundation Trust - Reino Unido
St George’s, University of London - Reino Unido
10 REPETTO-LISBOA, MARIA GABRIELA Mujer Universidad del Desarrollo - Chile
Facultad de Medicina Clínica Alemana Universidad del Desarrollo - Chile
11 Scurr, I. Mujer Univ Hosp Bristol & Weston NHS Trust - Reino Unido
University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido
12 Varghese, V. Hombre Univ Hosp Wales - Reino Unido
University Hospital of Wales - Reino Unido
13 Low, Karen Mujer Univ Hosp Bristol & Weston NHS Trust - Reino Unido
Univ Bristol - Reino Unido
University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido
Centre for Academic Child Health - Reino Unido

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Fondo Nacional de Desarrollo Científico y Tecnológico
Wellcome Trust
Health Innovation Challenge Fund
Wellcome
Department of Health
Wellcome Sanger Institute
Agencia Nacional de Investigación y Desarrollo
Department of Health and Social Care
ANID Chile FONDECYT
Cambridge South REC
National Institute for Health and Care Research
Republic of Ireland REC
European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA
Australian Centre for Geomechanics

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Health Innovation Challenge Fund, Grant/Award Number: HICF-1009-003; Wellcome and the Department of Health; Wellcome Sanger Institute, Grant/Award Number: WT098051; Cambridge South REC, Grant/Award Number: 10/H0305/83; Republic of Ireland REC, Grant/Award Number: GEN/284/12; ANID Chile FONDECYT, Grant/Award Number: 1211411; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Grant/Award Number: 3HP-HP-FPA ERN-01-2016/739516
The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (Grant number HICF-1009-003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute (Grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of Wellcome or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network. GMR is funded by ANID Chile FONDECYT (Grant number 1211411). One of the author(s) (ACG) of this publication is a member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA (EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516).

Muestra la fuente de financiamiento declarada en la publicación.